Clinical Trials Logo

Anal Cancer clinical trials

View clinical trials related to Anal Cancer.

Filter by:

NCT ID: NCT00568425 Terminated - Anal Cancer Clinical Trials

QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT

Start date: September 2005
Phase:
Study type: Observational

The purpose of this study is show that intensity-modulated radiotherapy (IMRT), as compared with conventional radiotherapy, improves the precision of tumor targeting and reduces the acute and late effects of radiation toxicity when used to treat anal cancer. Results from this work will provide a basis for incorporating the use of IMRT to treat anal cancer in future treatment protocols.

NCT ID: NCT00532987 Terminated - Rectal Cancer Clinical Trials

Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer

Start date: December 2003
Phase: N/A
Study type: Observational

Treatment of rectal cancer often consists of surgical resection of the tumor. Chemotherapy and/or radiotherapy are frequently given before or after surgery. In this study, we wish to learn if there are differences in the treatment effectiveness or in the quality of life of patients based on their type of treatment (e.g. Radiotherapy and chemotherapy before or after surgery). Information from this questionnaire collected from you and other patients may help improve the quality of life of rectal cancer patients in the future. Medical information on your tumor, treatment received, and side effects will be compiled and maintained in a database to learn more about outcomes of treatment for rectal cancer.

NCT ID: NCT00394602 Terminated - Pancreatic Cancer Clinical Trials

Chemoradiation-Induced Nausea and Emesis: Quality of Life

Start date: April 7, 2004
Phase:
Study type: Observational

The primary objectives of this study are: 1. To assess the preferences of cancer patients scheduled to receive chemoradiation and caregiver controls for side-effects of chemoradiation. 1. To compare preferences of cancer patients to those of healthy individuals. 2. To compare how patients' preferences for side-effects of chemoradiation change over time. 2. To longitudinally assess the quality of life of cancer patients scheduled to receive chemoradiation. 3. To determine the impact of nausea and vomiting associated with chemoradiation on patients' quality of life and evaluate potential change throughout the duration of chemoradiation treatment.

NCT ID: NCT00267787 Terminated - Rectal Cancer Clinical Trials

Molecular Genetic and Pathological Studies of Anal Tumors

Start date: September 2004
Phase:
Study type: Observational

Study the Genetics of Anal Cancer

NCT ID: NCT00068744 Terminated - Anal Cancer Clinical Trials

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

Start date: July 2003
Phase: Phase 2/Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as mitomycin, fluorouracil, and cisplatin, use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. It is not yet known whether radiation therapy and mitomycin are more effective when combined with fluorouracil or with cisplatin in treating anal cancer . PURPOSE: This randomized phase II/III trial is studying how well giving radiation therapy and mitomycin together with fluorouracil works compared to radiation therapy, mitomycin, and cisplatin in treating patients with locally advanced anal cancer.